My Watchlist

Top Indices

Nasdaq Composite

SPX

My Portfolio

MIRA Pharmaceuticals, Inc. - Common Stock (NQ:MIRA)

1.630 +0.020 (+1.24%)

Streaming Delayed Price Updated: 4:00 PM EST, Dec 19, 2025 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about MIRA Pharmaceuticals, Inc. - Common Stock

< Previous 1 2 3 4 5 6 Next >

Why ReNew Energy Global Shares Are Trading Higher By Around 14%? Here Are Other Stocks Moving In Monday's Mid-Day Session ↗

November 20, 2023

Shares of ReNew Energy Global Plc (NASDAQ: RNW) gained during Monday’s session following strong quarterly sales. ReNew Energy Global posted quarterly sales of $345.00 million, topping market estimates...

Via Benzinga

12 Health Care Stocks Moving In Monday's Intraday Session ↗

November 20, 2023

Via Benzinga

Why Is Depression Focused MIRA Pharmaceuticals Stock Trading Higher Today? ↗

November 20, 2023

MIRA Pharmaceuticals Inc (NASDAQ: MIRA) announced a partnership with MIRALOGX, LLC, an intellectual property holding company

Via Benzinga

Topics Intellectual Property

12 Health Care Stocks Moving In Thursday's After-Market Session ↗

November 16, 2023

Via Benzinga

12 Health Care Stocks Moving In Wednesday's Intraday Session ↗

November 15, 2023

Via Benzinga

12 Health Care Stocks Moving In Monday's Pre-Market Session ↗

October 23, 2023

Via Benzinga

Why Biophytis Shares Are Trading Higher By Around 32%; Here Are 20 Stocks Moving Premarket ↗

September 25, 2023

Gainers FaZe Holdings Inc. (NASDAQ: FAZE) shares rose 64.7% to $0.2520 in pre-market trading after falling over 4% on Friday.

Via Benzinga

Why Brainstorm Cell Therapeutics Shares Are Trading Lower By 33%? Here Are Other Stocks Moving In Monday's Mid-Day Session ↗

September 25, 2023

Gainers TransCode Therapeutics, Inc. (NASDAQ: RNAZ) shares jumped 308% to $2.71 after the company announced pre-clinical gliblastoma results with its lead candidate, TTX-MC138.

Via Benzinga

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday ↗

September 25, 2023

It's time for another dive into the biggest pre-market stock movers as we check out all of the latest news on Monday morning!

Via InvestorPlace

12 Health Care Stocks Moving In Monday's Intraday Session ↗

September 18, 2023

Via Benzinga

Why Nikola Shares Are Trading Higher By 33%? Here Are Other Stocks Moving In Monday's Mid-Day Session ↗

September 18, 2023

Gainers

Via Benzinga

12 Health Care Stocks Moving In Wednesday's Intraday Session ↗

September 13, 2023

Via Benzinga

Why Tenon Medical Shares Are Trading Lower By 34%; Here Are 20 Stocks Moving Premarket ↗

September 11, 2023

Gainers

Via Benzinga

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday ↗

September 11, 2023

We're starting off the workweek right with a breakdown of the biggest pre-market stock movers worth watching on Monday morning!

Via InvestorPlace

12 Health Care Stocks Moving In Thursday's Pre-Market Session ↗

September 07, 2023

Via Benzinga

Why WestRock Shares Are Trading Higher By 12%; Here Are 20 Stocks Moving Premarket ↗

September 07, 2023

Gainers

Via Benzinga

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday ↗

September 07, 2023

We're diving into the biggest pre-market stock movers as we check out all of the hottest news happening on Thursday morning!

Via InvestorPlace

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday ↗

August 30, 2023

Pre-market stock movers are a hot topic on Wednesday morning and we're covering the shares rising and falling this morning!

Via InvestorPlace

MIRA Pharmaceuticals, Inc. Discusses Potential of Revolutionary THC Analog Drug, MIRA1a, with The Stock Day Podcast

August 09, 2023

Via ACCESSWIRE

Synthetic THC Researcher Mira Pharmaceuticals Debuts On Nasdaq ↗

August 06, 2023

Mira Pharmaceuticals made its public debut on the Nasdaq this week. The company raised $8.9 million in its IPO, which it intends to use towards accelerating toxicology and clinical research of its...

Via Talk Markets

Biopharma Company Working On Synthetic THC Drug To Treat Anxiety Launches NASDAQ IPO ↗

August 03, 2023

Pre-clinical-stage biopharma company, MIRA Pharmaceuticals (NASDAQ: MIRA) launched its initial public offering Thursday and is trading $6.72 per share at the time of reporting.

Via Benzinga

< Previous 1 2 3 4 5 6 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.